The Reproductive Medicine Group, Tampa, Florida.
Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, University of Iowa Carver College of Medicine, Iowa City, Iowa.
Fertil Steril. 2022 Apr;117(4):803-810. doi: 10.1016/j.fertnstert.2022.01.008. Epub 2022 Feb 23.
To determine if transfer of fresh embryos derived from fresh or cryopreserved donor oocytes yields a higher live birth rate.
Historical cohort study.
Society for Assisted Reproductive Technology Clinic Outcome Reporting System database.
PATIENT(S): A total of 24,663 fresh embryo transfer cycles of donor oocytes.
INTERVENTION(S): None.
MAIN OUTCOME MEASURE(S): The primary outcome was live births per number of embryos transferred on day 5. The secondary outcomes included number of infants per embryo transfer, surplus embryos cryopreserved, and characterization of US oocyte recipients.
RESULT(S): A total of 16,073 embryo transfers were from fresh oocytes and 8,590 were from cryopreserved oocytes. Recipient age, body mass index (BMI), gravidity, and parity were similar between the groups. Most recipients were of White non-Hispanic race (66.9%), followed by Asian (13.7%), Black non-Hispanic (9.3%), and Hispanic (7.2%). Fresh oocyte cycles were more likely to use elective single embryo transfer (42.5% vs. 37.8%) or double embryo transfer (53.2% vs. 50.4%) and resulted in more surplus embryos for cryopreservation (4.6 vs. 1.2). The live birth rate from fresh oocytes was 57.5% vs. 49.7% from cryopreserved oocytes. Negative predictors of live birth included the use of cryopreserved oocytes (odds ratio [OR] 0.731, 95% confidence interval [CI] 0.665-0.804), Black non-Hispanic race (OR 0.603, 95% CI 0.517-0.703), Asian race (OR 0.756, 95% CI 0.660-0.867), and increasing recipient BMI (OR 0.982, 95% CI 0.977-0.994) after controlling for recipient age, number of embryos transferred on day 5, and unexplained infertility diagnosis. The proportion of multifetal deliveries was greater in cycles utilizing fresh (26.4%) vs. cryopreserved (20.6%) oocytes.
CONCLUSION(S): The live birth rate is higher with use of fresh oocytes vs. cryopreserved oocytes in fresh embryo transfer cycles. Negative live birth predictors include recipient Black non-Hispanic or Asian race and increasing BMI.
确定新鲜胚胎与冷冻保存的供体卵母细胞的移植是否能提高活产率。
历史队列研究。
辅助生殖技术协会临床结果报告系统数据库。
共 24663 个新鲜胚胎移植周期的供体卵母细胞。
无。
主要结局是第 5 天移植胚胎的活产数/移植胚胎数。次要结局包括每例胚胎移植的婴儿数、冷冻保存的多余胚胎数以及美国供卵者受体的特征。
共 16073 个胚胎移植来自新鲜卵母细胞,8590 个来自冷冻卵母细胞。两组间的受体年龄、体重指数(BMI)、孕次和产次相似。大多数受体为白人非西班牙裔(66.9%),其次是亚洲人(13.7%)、黑人非西班牙裔(9.3%)和西班牙裔(7.2%)。新鲜卵母细胞周期更倾向于选择性单胚胎移植(42.5%比 37.8%)或双胚胎移植(53.2%比 50.4%),并导致更多的多余胚胎冷冻保存(4.6 比 1.2)。新鲜卵母细胞的活产率为 57.5%,而冷冻卵母细胞的活产率为 49.7%。活产的负预测因素包括使用冷冻卵母细胞(比值比[OR]0.731,95%置信区间[CI]0.665-0.804)、黑人非西班牙裔(OR 0.603,95%CI 0.517-0.703)、亚洲人(OR 0.756,95%CI 0.660-0.867)和受体 BMI 增加(OR 0.982,95%CI 0.977-0.994),在控制受体年龄、第 5 天移植胚胎数和不明原因不孕诊断后。使用新鲜卵母细胞的周期多胎分娩比例高于使用冷冻卵母细胞的周期(26.4%比 20.6%)。
新鲜胚胎移植周期中,新鲜卵母细胞的活产率高于冷冻卵母细胞。活产的负预测因素包括受体为黑人非西班牙裔或亚洲人以及 BMI 增加。